Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Follicular | 12 | 2024 | 460 | 3.090 |
Why?
|
Thymus Neoplasms | 4 | 2024 | 274 | 1.360 |
Why?
|
Thymoma | 3 | 2023 | 188 | 1.260 |
Why?
|
Lymphoma, B-Cell | 4 | 2022 | 945 | 0.820 |
Why?
|
Translocation, Genetic | 3 | 2023 | 1394 | 0.670 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2020 | 82 | 0.660 |
Why?
|
Splenomegaly | 1 | 2020 | 192 | 0.650 |
Why?
|
Lymphoma, T-Cell | 6 | 2024 | 308 | 0.620 |
Why?
|
Parotid Gland | 1 | 2018 | 178 | 0.560 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2025 | 1437 | 0.550 |
Why?
|
Burkitt Lymphoma | 2 | 2025 | 338 | 0.550 |
Why?
|
Syphilis | 1 | 2018 | 243 | 0.490 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 180 | 0.480 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2017 | 335 | 0.440 |
Why?
|
Lymphoma | 4 | 2022 | 1898 | 0.440 |
Why?
|
Gene Rearrangement | 3 | 2020 | 1146 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2021 | 1406 | 0.400 |
Why?
|
Skin Neoplasms | 6 | 2022 | 5863 | 0.390 |
Why?
|
Infectious Mononucleosis | 1 | 2012 | 133 | 0.390 |
Why?
|
Mutation | 11 | 2023 | 30238 | 0.380 |
Why?
|
Chromosomes, Human, Pair 11 | 3 | 2025 | 411 | 0.380 |
Why?
|
Myasthenia Gravis | 1 | 2013 | 215 | 0.360 |
Why?
|
Myositis | 1 | 2013 | 269 | 0.350 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2021 | 30 | 0.330 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1494 | 0.320 |
Why?
|
Immunophenotyping | 3 | 2023 | 1864 | 0.320 |
Why?
|
Scapula | 1 | 2010 | 175 | 0.310 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2021 | 210 | 0.310 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.300 |
Why?
|
Endometrial Neoplasms | 1 | 2016 | 1382 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2021 | 190 | 0.270 |
Why?
|
Bone Diseases | 1 | 2010 | 416 | 0.270 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 13014 | 0.270 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1418 | 0.250 |
Why?
|
Sarcoma, Myeloid | 2 | 2018 | 52 | 0.250 |
Why?
|
Lymph Nodes | 3 | 2020 | 3474 | 0.240 |
Why?
|
Biopsy | 5 | 2018 | 6793 | 0.230 |
Why?
|
Erythrocytes, Abnormal | 1 | 2023 | 121 | 0.210 |
Why?
|
Edema | 3 | 2017 | 765 | 0.210 |
Why?
|
Canaries | 1 | 2002 | 6 | 0.210 |
Why?
|
Leg | 2 | 2018 | 1088 | 0.200 |
Why?
|
Cell Nucleus | 2 | 2023 | 2885 | 0.200 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3603 | 0.200 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 594 | 0.190 |
Why?
|
Myeloproliferative Disorders | 2 | 2021 | 616 | 0.190 |
Why?
|
Dendritic Cells | 3 | 2021 | 2747 | 0.180 |
Why?
|
Lectins, C-Type | 1 | 2024 | 594 | 0.180 |
Why?
|
Oncogenes | 2 | 2023 | 1234 | 0.180 |
Why?
|
HIV-1 | 1 | 2018 | 6961 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 84 | 0.170 |
Why?
|
Cell Shape | 2 | 2023 | 371 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2024 | 489 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2016 | 2521 | 0.170 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 125 | 0.170 |
Why?
|
Chromosome Aberrations | 4 | 2025 | 1778 | 0.170 |
Why?
|
Humans | 53 | 2025 | 768166 | 0.160 |
Why?
|
Sarcoma | 2 | 2021 | 1806 | 0.160 |
Why?
|
Hematologic Diseases | 1 | 2023 | 498 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13586 | 0.160 |
Why?
|
Cathepsins | 1 | 2020 | 243 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 359 | 0.160 |
Why?
|
Thymus Gland | 1 | 2024 | 1266 | 0.160 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1907 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2023 | 9015 | 0.160 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2021 | 648 | 0.150 |
Why?
|
Duodenal Neoplasms | 1 | 2018 | 114 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 354 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 53 | 0.150 |
Why?
|
Orotate Phosphoribosyltransferase | 1 | 2017 | 5 | 0.140 |
Why?
|
Orotidine-5'-Phosphate Decarboxylase | 1 | 2017 | 8 | 0.140 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 308 | 0.140 |
Why?
|
Antigen Presentation | 2 | 2020 | 1251 | 0.140 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11095 | 0.140 |
Why?
|
Middle Aged | 23 | 2025 | 223492 | 0.140 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.140 |
Why?
|
Mutation, Missense | 2 | 2018 | 2592 | 0.140 |
Why?
|
Exophthalmos | 1 | 2018 | 100 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 2 | 2021 | 1062 | 0.140 |
Why?
|
Sphenoid Bone | 1 | 2018 | 176 | 0.140 |
Why?
|
rho GTP-Binding Proteins | 1 | 2018 | 279 | 0.130 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 921 | 0.130 |
Why?
|
Cell Proliferation | 1 | 2012 | 10474 | 0.130 |
Why?
|
Thiophenes | 1 | 2020 | 570 | 0.130 |
Why?
|
Receptors, IgG | 1 | 2019 | 564 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 362 | 0.130 |
Why?
|
Hydronephrosis | 1 | 2017 | 274 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 701 | 0.130 |
Why?
|
Chromosomes, Human | 1 | 2017 | 438 | 0.120 |
Why?
|
Genomics | 3 | 2021 | 5926 | 0.120 |
Why?
|
Neovascularization, Physiologic | 1 | 2002 | 1369 | 0.120 |
Why?
|
HIV Infections | 2 | 2020 | 17569 | 0.120 |
Why?
|
Culture Media | 1 | 2017 | 898 | 0.120 |
Why?
|
Thymus Hyperplasia | 1 | 2014 | 32 | 0.120 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2013 | 40 | 0.110 |
Why?
|
Thymectomy | 1 | 2014 | 200 | 0.110 |
Why?
|
Male | 25 | 2025 | 364719 | 0.110 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 582 | 0.110 |
Why?
|
Tomography, X-Ray | 1 | 2013 | 58 | 0.110 |
Why?
|
Multienzyme Complexes | 1 | 2017 | 664 | 0.110 |
Why?
|
Splenectomy | 1 | 2015 | 392 | 0.110 |
Why?
|
Refractometry | 1 | 2013 | 57 | 0.110 |
Why?
|
Leukemia, B-Cell | 1 | 2013 | 86 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2025 | 8647 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 9092 | 0.110 |
Why?
|
I-kappa B Kinase | 1 | 2014 | 250 | 0.110 |
Why?
|
Back Pain | 1 | 2017 | 548 | 0.110 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2020 | 3626 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4793 | 0.100 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 977 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5717 | 0.100 |
Why?
|
Aged | 17 | 2025 | 171504 | 0.100 |
Why?
|
Female | 24 | 2025 | 397192 | 0.100 |
Why?
|
Autopsy | 1 | 2016 | 1011 | 0.100 |
Why?
|
Reed-Sternberg Cells | 1 | 2012 | 78 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59629 | 0.100 |
Why?
|
Face | 1 | 2018 | 1029 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2954 | 0.090 |
Why?
|
Lung | 1 | 2010 | 10099 | 0.090 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1164 | 0.090 |
Why?
|
Immunoglobulin Light Chains | 1 | 2012 | 289 | 0.090 |
Why?
|
Pyrimidines | 2 | 2020 | 3048 | 0.090 |
Why?
|
Uric Acid | 1 | 2017 | 805 | 0.090 |
Why?
|
Sulfonamides | 1 | 2020 | 1982 | 0.090 |
Why?
|
Radiography | 2 | 2013 | 6983 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 30010 | 0.090 |
Why?
|
Specimen Handling | 1 | 2015 | 708 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1614 | 0.090 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 630 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4427 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10266 | 0.080 |
Why?
|
NF-kappa B | 2 | 2018 | 2493 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3948 | 0.080 |
Why?
|
Body Height | 1 | 2016 | 1565 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4528 | 0.080 |
Why?
|
Eye | 1 | 2013 | 712 | 0.080 |
Why?
|
Spleen | 1 | 2015 | 2295 | 0.080 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 614 | 0.080 |
Why?
|
Adult | 13 | 2021 | 223646 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3800 | 0.080 |
Why?
|
MicroRNAs | 1 | 2025 | 3803 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 78 | 0.080 |
Why?
|
Necrosis | 1 | 2012 | 1616 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2048 | 0.070 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2009 | 425 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3681 | 0.070 |
Why?
|
Pain | 2 | 2013 | 5100 | 0.070 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1082 | 0.070 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1232 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2025 | 9538 | 0.070 |
Why?
|
Signal Transduction | 6 | 2020 | 23645 | 0.070 |
Why?
|
Cough | 1 | 2010 | 598 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5703 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4354 | 0.060 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 5505 | 0.060 |
Why?
|
Neurons | 2 | 2002 | 9514 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5804 | 0.060 |
Why?
|
Infant | 4 | 2018 | 36535 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2565 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5341 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2018 | 20760 | 0.060 |
Why?
|
Crohn Disease | 1 | 2018 | 2295 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4627 | 0.060 |
Why?
|
Child | 6 | 2021 | 80917 | 0.060 |
Why?
|
Mice | 9 | 2024 | 82029 | 0.060 |
Why?
|
Antigens, CD | 2 | 2013 | 4035 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1061 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2614 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2167 | 0.060 |
Why?
|
Young Adult | 6 | 2020 | 60066 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2024 | 3611 | 0.050 |
Why?
|
Myocardium | 1 | 2016 | 4788 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20227 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 190 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12840 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3833 | 0.050 |
Why?
|
Animals | 11 | 2024 | 169246 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 1399 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2009 | 843 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1743 | 0.050 |
Why?
|
Plaque, Atherosclerotic | 1 | 2013 | 1551 | 0.050 |
Why?
|
Child, Preschool | 2 | 2016 | 42669 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 324 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9615 | 0.050 |
Why?
|
Adolescent | 5 | 2019 | 89169 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.040 |
Why?
|
Epithelioid Cells | 1 | 2020 | 60 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 671 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 17140 | 0.040 |
Why?
|
Algorithms | 2 | 2018 | 14164 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2020 | 318 | 0.040 |
Why?
|
Antigens, CD1d | 1 | 2020 | 225 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18412 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9419 | 0.040 |
Why?
|
Lymphokines | 1 | 2002 | 924 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 662 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10873 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 752 | 0.040 |
Why?
|
Brain | 2 | 2002 | 27360 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2010 | 2085 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2002 | 605 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 19015 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4120 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 96 | 0.040 |
Why?
|
Skin | 2 | 2022 | 4503 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1750 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2018 | 235 | 0.030 |
Why?
|
Cohort Studies | 3 | 2019 | 41754 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2020 | 948 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 233 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2018 | 342 | 0.030 |
Why?
|
Forensic Pathology | 1 | 2016 | 23 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2017 | 102 | 0.030 |
Why?
|
Entropy | 1 | 2017 | 211 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2009 | 1883 | 0.030 |
Why?
|
Postmortem Changes | 1 | 2016 | 119 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1329 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2019 | 537 | 0.030 |
Why?
|
Cell Separation | 1 | 2001 | 1728 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1441 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 633 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6498 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 770 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1536 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13676 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13671 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9523 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 663 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2211 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 561 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4473 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1627 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5196 | 0.030 |
Why?
|
Immune Evasion | 1 | 2018 | 375 | 0.030 |
Why?
|
Cytokines | 2 | 2020 | 7453 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1737 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2528 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2810 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1338 | 0.030 |
Why?
|
Serum Albumin | 1 | 2016 | 677 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16726 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1057 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2540 | 0.030 |
Why?
|
X-Rays | 1 | 2013 | 311 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1081 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1779 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2410 | 0.020 |
Why?
|
Dermis | 1 | 2013 | 203 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2012 | 26422 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2012 | 310 | 0.020 |
Why?
|
Fluorouracil | 1 | 2017 | 1652 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2012 | 387 | 0.020 |
Why?
|
Testosterone | 1 | 2002 | 2491 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 412 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3514 | 0.020 |
Why?
|
Melphalan | 1 | 2012 | 421 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2267 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4283 | 0.020 |
Why?
|
Cell Movement | 1 | 2002 | 5210 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5797 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1135 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 494 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1903 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7951 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2675 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2512 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3409 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3463 | 0.020 |
Why?
|
Dogs | 1 | 2013 | 3845 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1397 | 0.020 |
Why?
|
Urban Health Services | 1 | 2009 | 177 | 0.020 |
Why?
|
Stem Cells | 1 | 2001 | 3537 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13421 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14729 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5902 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3074 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5151 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2012 | 839 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11878 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 435 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2009 | 497 | 0.020 |
Why?
|
Thoracotomy | 1 | 2009 | 374 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9263 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4446 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2227 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3445 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3623 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11669 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7608 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21206 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2257 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9343 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9561 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4352 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2014 | 81762 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39348 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7598 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18349 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12168 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9495 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8741 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8317 | 0.010 |
Why?
|
Mammography | 1 | 2013 | 2433 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6316 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2009 | 1156 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1365 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8890 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2046 | 0.010 |
Why?
|
Tissue Transplantation | 1 | 2001 | 128 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 2001 | 261 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1238 | 0.010 |
Why?
|
Retroviridae | 1 | 2001 | 846 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2784 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 838 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65371 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8080 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 1092 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2065 | 0.010 |
Why?
|
Neuroglia | 1 | 2001 | 960 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18065 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3772 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2633 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2001 | 1890 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36743 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4413 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40218 | 0.000 |
Why?
|